Why healthcare open innovation is failing for nanomedicinesEATON, Michael A. W.European journal of nanomedicine (Print). 2013, Vol 5, Num 4, pp 213-215, issn 1662-5986, 3 p.Article

Les nanomédicaments : Nanomédecine: Du labo au marchéFATTAL, Elias; BOCHOT, Amélie; HILLAIREAU, Hervé et al.Biofutur (Puteaux). 2012, Num 333, pp 26-29, issn 0294-3506, 4 p.Article

First cross border conference on nanosciences and materials for health. Nano SMH (21-25 june 2010, Pont-à-Mousson)Cross border conference on nanosciences and materials for health. 2010, 1Vol, 64 p.Conference Proceedings

Innovation in Nanomedicine through Materials NanoarchitectonicsKUJAWA, Piotr; WINNIK, Françoise M.Langmuir. 2013, Vol 29, Num 24, pp 7354-7361, issn 0743-7463, 8 p.Article

Le business model des biotechnologies est-il adapté à la France ? : LES BIOTECHS FRANÇAISES SONT-ELLES COMPÉTITIVES ?SADI, Nacer-Eddine; CATHERINE, David; THEODOSIOU, Maria et al.Biofutur (Puteaux). 2014, Num 350, pp 32-35, issn 0294-3506, 4 p.Article

Des nanotechnologies pour le diagnostic : Nanomédecine: Du labo au marchéTEXIER, Isabelle; COLL, Jean-Luc; VAUCHIER, Claude et al.Biofutur (Puteaux). 2012, Num 333, pp 37-41, issn 0294-3506, 5 p.Article

Nanoparticules magnétiques au cœur des cellules: des outils pour les thérapies cellulaires : Les nanomédicaments réalités et perspectives = Magnetic nanoparticles as tools for cell therapyWILHELM, Claire; GAZEAU, Florence.Biologie aujourd'hui. 2012, Vol 206, Num 4, pp 273-284, issn 2105-0678, 12 p.Conference Paper

Mechanisms of cooperation in cancer nanomedicine: towards systems nanotechnologyHAUERT, Sabine; BHATIA, Sangeeta N.Trends in biotechnology (Regular ed.). 2014, Vol 32, Num 9, pp 448-455, issn 0167-7799, 8 p.Article

Les nanoparticules en radiothérapie : Nanomédecine: Du labo au marchéBILLOTEY, Claire.Biofutur (Puteaux). 2012, Num 333, pp 32-36, issn 0294-3506, 5 p.Article

Micro- et nanotechnologies pour l'administration de médicaments au niveau cérébral : Les nanomédicaments réalités et perspectives = Conception and studies of micro and nanomedicines for brain applicationsBENOIT, Jean-Pierre.Biologie aujourd'hui. 2012, Vol 206, Num 4, pp 263-271, issn 2105-0678, 9 p.Conference Paper

Nanotechnology for vaccine developmentTOTH, Istvan; SKWARCZYNSKI, Mariusz.Nanomedicine (London. Print). 2014, Vol 9, Num 17, issn 1743-5889, [112 p.]Serial Issue

CARDIOVASCULAR NANOMEDICINELETOURNEUR, Didier.European journal of nanomedicine (Print). 2014, Vol 6, Num 2, issn 1662-5986, 61 p.Serial Issue

Une mégaprogrammation pour les nanotechnologiesDOUHI, Safi.Biofutur (Puteaux). 2012, Num 333, pp 50-51, issn 0294-3506, 2 p.Article

Des nanovecteurs pour l'ARN interférence thérapeutique : Nanomédecine: Du labo au marchéNAVARRO, Fabrice; SULPICE, Eric; GIDROL, Xavier et al.Biofutur (Puteaux). 2012, Num 333, pp 30-31, issn 0294-3506, 2 p.Article

Frontiers in cancer nanomedicine: directing mass transport through biological barriersFERRARI, Mauro.Trends in biotechnology (Regular ed.). 2010, Vol 28, Num 4, pp 181-188, issn 0167-7799, 8 p.Article

International Nanomedicine and Drug Delivery Symposium (NanoDDS'07)Journal of controlled release. 2008, Vol 130, Num 2, pp 98-138, issn 0168-3659, 40 p.Conference Paper

Assessing in vivo toxicity of graphene materials: current methods and future outlookYUFEI MA; HE SHEN; XIAOLONG TU et al.Nanomedicine (London. Print). 2014, Vol 9, Num 10, pp 1565-1580, issn 1743-5889, 16 p.Article

Amino and carboxyl plasma functionalization of collagen films for tissue engineering applicationsTARABALLI, F; ZANINI, S; LUPO, C et al.Journal of colloid and interface science. 2013, Vol 394, pp 590-597, issn 0021-9797, 8 p.Article

Structural modulation of the biological activity of gold nanoparticles functionalized with a carbonic anhydrase inhibitorBELLISSIMA, Francesca; CARTA, Fabrizio; INNOCENTI, Alessio et al.The European physical journal. E, Soft matter (Print). 2013, Vol 36, Num 5, issn 1292-8941, 3648.1-3648.13Article

La nanopsychiatrie. Le rôle potentiel des nanotechnologies dans l'avenir de la psychiatrie. Une revue systématique = Nanopsychiatry. The potential role of nanotechnologies in the future of psychiatry. A systematic reviewFOND, G; MIOT, S.L' Encéphale (Paris). 2013, Vol 39, Num 4, pp 252-257, issn 0013-7006, 6 p.Article

Engineering nanomedicines using stimuli-responsive biomaterialsYAPEI WANG; BYRNE, James D; NAPIER, Mary E et al.Advanced drug delivery reviews. 2012, Vol 64, Num 11, pp 1021-1030, issn 0169-409X, 10 p.Article

Highlights from the latest articles in nanoparticle cellular interactionsLONEZ, Caroline; RUYSSCHAERT, Jean-Marie.Nanomedicine (London. Print). 2014, Vol 9, Num 16, pp 2441-2443, issn 1743-5889, 3 p.Article

Les révolutions de la technomédecine : Vieillir... jusqu'à quand ?ALEXANDRE, Lurent.Biofutur (Puteaux). 2012, Num 329, pp 48-49, issn 0294-3506, 2 p.Article

Full-length single-walled carbon nanotubes decorated with streptavidin-conjugated quantum dots as multivalent intracellular fluorescent nanoprobesBOTTINI, Massimo; CERIGNOLI, Fabio; DAWSON, Marcia I et al.Biomacromolecules. 2006, Vol 7, Num 8, pp 2259-2263, issn 1525-7797, 5 p.Article

LA NANOMEDECINE, SES APPLICATIONS POSSIBLES EN SANTÉ ANIMALE, LE POINT DE VUE DES INDUSTRIELS = NANOMEDECINE, ITS POTENTIAL APPLICATIONS IN ANIMAL HEALTH, THE INDUSTRIAL POINT OF VIEWDELAVEAU, Jean.Bulletin de l'Académie vétérinaire de France. 2013, Vol 166, Num 2, pp 147-154, issn 0001-4192, 8 p.Article